Current Litigation & Lawsuit News News

Blood Thinner, Xarelto

First Xarelto Bleeding Lawsuits Filed; FDA Rejects New Use

Drug giants Bayer and Johnson & Johnson face the first lawsuits related to safety concerns for the billion-dollar blood thinner Xarelto, according to Reuters. Plaintiffs filed claims after severe internal bleeding sent them to the hospital. In those cases, patients took Xarelto (rivaroxaban), and their claims blame the excessive bleeding on that use. Unlike warfarin, […]

Aug 4, 2014 Read More...

Granuflo and Naturalyte, dialysis drugs

Louisiana Files Lawsuit against GranuFlo, NaturaLyte maker Fresenius

The state of Louisiana sued Fresenius Medical Care North America and nearly 100 of its clinics statewide after two of its dialysis drugs – NaturaLyte and GranuFlo – were linked to fatal heart attacks, strokes and other conditions. Louisiana officials claim Fresenius knew that GranuFlo and NaturaLyte could elevate patients’ bicarbonate levels and therefor increase […]

Jul 10, 2014 Read More...

Testosterone Lawsuits Consolidated into MDL

Federal Testosterone Lawsuits Consolidated in MDL in Chicago

Federal lawsuits against the makers of AndroGel and other testosterone replacement therapy (TRT) products will be consolidated in the U.S. District Court for the Northern District of Illinois, where the first cases were filed this year. The U.S. Judicial Panel on Multidistrict Litigation (MDL) ordered all federal lawsuits involving testosterone therapy products to be tried […]

Jun 18, 2014 Read More...

Pradaxa Settles Bleeding Lawsuits

Boehringer Ingelheim to Pay $650M to Settle 4,000 Pradaxa Lawsuits

German manufacturer Boehringer Ingelheim announced today that it will pay $650 million to settle all 4,000 state and federal lawsuits over its blood thinner Pradaxa (dabigatran). That amounts to an average of $162,500 for each claimant. The lawsuits state that Pradaxa can cause bleeding events that cannot be controlled and are sometimes fatal. In 2011 […]

May 28, 2014 Read More...

courtroom

Juries: Actos Manufacturer Not Responsible for Bladder Cancer

In verdicts that came just a week apart, two juries concluded that Takeda Pharmaceuticals is not responsible when Actos users develop bladder cancer. A Chicago jury sided with Takeda on May 15 in a case brought by the widow of William Whitlatch, who died of bladder cancer in 2006 after taking the diabetes drug. And […]

May 16, 2014 Read More...

infuse bone graft

Medtronic Settles 950 INFUSE Bone Graft Lawsuits for $22M

Medtronic Inc. announced today it will pay $22 million to settle nearly 1,000 lawsuits over its INFUSE Bone Graft, amounting to less than $25,000 per claimant. The company refused to admit liability over the controversial product, which can cause serious complications in patients. The Minneapolis-based company also said it is setting aside between $120 million […]

May 6, 2014 Read More...

Loading